SBH 10-Q Quarterly Report March 31, 2023 | Alphaminr
Sally Beauty Holdings, Inc.

SBH 10-Q Quarter ended March 31, 2023

SALLY BEAUTY HOLDINGS, INC.
10-Ks and 10-Qs
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
sbh-10q_20230331.htm
0001368458 false --09-30 2023 Q2 P4Y 0001368458 2022-10-01 2023-03-31 xbrli:shares 0001368458 2023-04-28 iso4217:USD 0001368458 2023-03-31 0001368458 2022-09-30 iso4217:USD xbrli:shares 0001368458 2023-01-01 2023-03-31 0001368458 2022-01-01 2022-03-31 0001368458 2021-10-01 2022-03-31 0001368458 us-gaap:CommonStockMember 2022-09-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001368458 us-gaap:RetainedEarningsMember 2022-09-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001368458 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001368458 2022-10-01 2022-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2022-12-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001368458 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001368458 us-gaap:CommonStockMember 2022-12-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001368458 us-gaap:RetainedEarningsMember 2022-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001368458 2022-12-31 0001368458 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001368458 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001368458 us-gaap:CommonStockMember 2023-03-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001368458 us-gaap:RetainedEarningsMember 2023-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001368458 us-gaap:CommonStockMember 2021-09-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001368458 us-gaap:RetainedEarningsMember 2021-09-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001368458 2021-09-30 0001368458 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001368458 2021-10-01 2021-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2021-12-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001368458 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001368458 us-gaap:CommonStockMember 2021-12-31 0001368458 us-gaap:RetainedEarningsMember 2021-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001368458 2021-12-31 0001368458 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001368458 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001368458 us-gaap:CommonStockMember 2022-03-31 0001368458 us-gaap:RetainedEarningsMember 2022-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001368458 2022-03-31 0001368458 us-gaap:ForeignExchangeContractMember 2022-10-01 2023-03-31 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-10-01 2023-03-31 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2023-03-31 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2022-09-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentAssetsMember 2022-09-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001368458 us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:AccruedLiabilitiesMember us-gaap:NondesignatedMember 2023-03-31 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:AccruedLiabilitiesMember us-gaap:NondesignatedMember 2022-09-30 0001368458 us-gaap:SeniorNotesMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001368458 us-gaap:SeniorNotesMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001368458 sbh:TermLoanBDueTwoThousandAndTwentyFourMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001368458 sbh:TermLoanBDueTwoThousandAndThirtyMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2017-08-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2021-07-01 2021-07-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2023-03-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2023-01-01 2023-03-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2022-10-01 2023-03-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2022-01-01 2022-03-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2021-10-01 2022-03-31 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001368458 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-09-30 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2022-09-30 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2022-10-01 2023-03-31 0001368458 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-10-01 2023-03-31 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2022-10-01 2023-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2023-03-31 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2023-03-31 0001368458 us-gaap:LineOfCreditMember 2023-03-31 0001368458 sbh:TLBTwentyThirtyMember sbh:SallyHoldingsAndSallyCapitalMember 2023-02-28 xbrli:pure 0001368458 sbh:TLBTwentyThirtyMember sbh:SallyHoldingsAndSallyCapitalMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-02-28 2023-02-28 0001368458 sbh:TLBTwentyThirtyMember sbh:SallyHoldingsAndSallyCapitalMember us-gaap:BaseRateMember 2023-02-28 2023-02-28 0001368458 sbh:TLBTwentyThirtyMember sbh:SallyHoldingsAndSallyCapitalMember 2023-02-28 2023-02-28 0001368458 sbh:TwoThousandTwentyFiveSeniorUnsecuredNotesMember sbh:SallyHoldingsAndSallyCapitalMember 2023-02-28 0001368458 sbh:TLBTwentyTwentyFourMember sbh:SallyHoldingsAndSallyCapitalMember 2023-02-28 0001368458 sbh:TLBTwentyTwentyFourMember sbh:SallyHoldingsAndSallyCapitalMember 2023-02-28 2023-02-28 sbh:instrument 0001368458 currency:MXN us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001368458 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001368458 currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2022-10-01 2023-03-31 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2021-10-01 2022-03-31 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2023-01-01 2023-03-31 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-03-31 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2023-03-31 0001368458 sbh:VariableRateTrancheMember us-gaap:InterestRateCapMember sbh:SallyHoldingsMember 2017-07-31 0001368458 sbh:VariableRateTrancheMember us-gaap:InterestRateCapMember sbh:SallyHoldingsMember 2022-10-01 2023-03-31 sbh:derivative 0001368458 sbh:VariableRateTrancheMember us-gaap:InterestRateCapMember sbh:SallyHoldingsMember 2023-01-01 2023-03-31 0001368458 sbh:VariableRateTrancheMember us-gaap:InterestRateCapMember sbh:SallyHoldingsMember 2021-10-01 2022-03-31 0001368458 currency:GBP us-gaap:NondesignatedMember 2023-03-31 0001368458 currency:CAD us-gaap:NondesignatedMember 2023-03-31 0001368458 currency:EUR us-gaap:NondesignatedMember 2023-03-31 0001368458 currency:MXN us-gaap:NondesignatedMember 2023-03-31 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-03-31 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-10-01 2023-03-31 0001368458 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:OperatingSegmentsMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:OperatingSegmentsMember 2021-10-01 2022-03-31 0001368458 us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0001368458 us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0001368458 us-gaap:OperatingSegmentsMember 2022-10-01 2023-03-31 0001368458 us-gaap:OperatingSegmentsMember 2021-10-01 2022-03-31 0001368458 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0001368458 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-03-31 0001368458 us-gaap:CorporateNonSegmentMember 2022-10-01 2023-03-31 0001368458 us-gaap:CorporateNonSegmentMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:DistributorSalesConsultantsMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:DistributorSalesConsultantsMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:DistributorSalesConsultantsMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:DistributorSalesConsultantsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-03-31 0001368458 sbh:DistributionCenterConsolidationAndStoreOptimizationPlanMember 2023-01-01 2023-03-31 0001368458 sbh:DistributionCenterConsolidationAndStoreOptimizationPlanMember 2022-10-01 2023-03-31 0001368458 sbh:TransformationPlanMember 2021-10-01 2022-03-31 0001368458 us-gaap:OtherRestructuringMember 2022-09-30 0001368458 sbh:SallyBeautySupplyMember sbh:ClosingCostsLeasesMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:ClosingCostsPayrollExpensesMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:ImpairmentPropertyAndEquipmentMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:InventoryTransferCostsMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember sbh:ImpairmentOperatingLeaseAssetsMember 2022-10-01 2023-03-31 0001368458 sbh:SallyBeautySupplyMember us-gaap:OtherRestructuringMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:ClosingCostsLeasesMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:ClosingCostsPayrollExpensesMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:ImpairmentPropertyAndEquipmentMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:InventoryTransferCostsMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember sbh:ImpairmentOperatingLeaseAssetsMember 2022-10-01 2023-03-31 0001368458 sbh:BeautySystemsGroupMember us-gaap:OtherRestructuringMember 2022-10-01 2023-03-31 0001368458 sbh:ClosingCostsLeasesMember 2022-10-01 2023-03-31 0001368458 sbh:ClosingCostsPayrollExpensesMember 2022-10-01 2023-03-31 0001368458 sbh:InventoryTransferCostsMember 2022-10-01 2023-03-31 0001368458 us-gaap:OtherRestructuringMember 2022-10-01 2023-03-31 0001368458 sbh:ImpairmentPropertyAndEquipmentMember 2022-10-01 2023-03-31 0001368458 sbh:ImpairmentOperatingLeaseAssetsMember 2022-10-01 2023-03-31 0001368458 sbh:ClosingCostsLeasesMember 2023-03-31 0001368458 sbh:ClosingCostsPayrollExpensesMember 2023-03-31 0001368458 sbh:InventoryTransferCostsMember 2023-03-31 0001368458 us-gaap:OtherRestructuringMember 2023-03-31 0001368458 us-gaap:InterestRateSwapMember us-gaap:SubsequentEventMember 2023-04-30 0001368458 us-gaap:InterestRateSwapMember us-gaap:SubsequentEventMember 2023-04-01 2023-04-30 0001368458 us-gaap:InterestRateSwapMember 2022-10-01 2023-03-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: MARCH 31, 2023

-OR-

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. 1-33145

SALLY BEAUTY HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware

36-2257936

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

3001 Colorado Boulevard

Denton , Texas

76210

(Address of principal executive offices)

(Zip Code)

( 940 ) 898-7500

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report): N/A

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered

Common Stock, $0.01 par value SBH The New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes No

As of April 28, 2023, there were 107,554,671 shares of the issuer’s common stock outstanding.


TABLE OF CONTENTS

Page

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

4

Condensed Consolidated Balance Sheets

4

Condensed Consolidated Statements of Earnings

5

Condensed Consolidated Statements of Comprehensive Income

6

Condensed Consolidated Statements of Stockholders’ Equity

7

Condensed Consolidated Statements of Cash Flows

8

Notes to Condensed Consolidated Financial Statements

9

Item 2. Management’s Discussion And Analysis Of Financial Condition And Results Of Operations

17

Item 3. Quantitative And Qualitative Disclosures About Market Risk

24

Item 4. Controls And Procedures

24

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

25

Item 1A. Risk Factors

25

Item 6. Exhibits

26


2


In this Quarterly Report, references to “the Company,” “Sally Beauty,” “our company,” “we,” “our,” “ours” and “us” refer to Sally Beauty Holdings, Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q and in the documents incorporated by reference herein which are not purely historical facts or which depend upon future events may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “target,” “can,” “could,” “may,” “should,” “will,” “would” or similar expressions may also identify such forward-looking statements.

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, which should be read in conjunction with the forward-looking statements in this report. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

3


PART I — FINANCIAL INFORMATION

Item 1.  Financial Statements.

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except par value data)

March 31,

2023

September 30,

2022

(Unaudited)

Assets

Current assets:

Cash and cash equivalents

$

61,620

$

70,558

Trade accounts receivable, net

30,540

34,102

Accounts receivable, other

45,123

38,175

Inventory

1,023,656

936,374

Other current assets

48,072

53,192

Total current assets

1,209,011

1,132,401

Property and equipment, net of accumulated depreciation of $ 841,760 at

March 31, 2023, and $ 820,811 at September 30, 2022

283,356

297,876

Operating lease assets

562,336

532,177

Goodwill

534,218

526,066

Intangible assets, excluding goodwill, net of accumulated amortization of

$ 29,921 at March 31, 2023, and $ 26,794 at September 30, 2022

50,533

50,315

Other assets

35,660

38,032

Total assets

$

2,675,114

$

2,576,867

Liabilities and Stockholders’ Equity

Current liabilities:

Current maturities of long-term debt

$

38,175

$

68,658

Accounts payable

265,075

275,717

Accrued liabilities

168,187

161,065

Current operating lease liabilities

154,255

157,734

Income taxes payable

4,949

4,740

Total current liabilities

630,641

667,914

Long-term debt

1,065,439

1,083,043

Long-term operating lease liabilities

444,819

424,762

Other liabilities

22,044

22,427

Deferred income tax liabilities, net

86,283

85,085

Total liabilities

2,249,226

2,283,231

Stockholders’ equity:

Common stock, $ 0.01 par value. Authorized 500,000 shares; 107,556 and

107,024 shares issued and 107,549 and 106,970 shares outstanding at

March 31, 2023, and September 30, 2022, respectively

1,076

1,070

Preferred stock, $ 0.01 par value. Authorized 50,000 shares; none issued

Additional paid-in capital

13,790

4,241

Accumulated earnings

531,370

440,172

Accumulated other comprehensive loss, net of tax

( 120,348

)

( 151,847

)

Total stockholders’ equity

425,888

293,636

Total liabilities and stockholders’ equity

$

2,675,114

$

2,576,867

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Earnings

(In thousands, except per share data)

(Unaudited)

Three Months Ended

Six Months Ended

March 31,

March 31,

2023

2022

2023

2022

Net sales

$

918,712

$

911,387

$

1,875,767

$

1,891,638

Cost of goods sold

450,373

446,055

918,854

926,177

Gross profit

468,339

465,332

956,913

965,461

Selling, general and administrative expenses

389,657

378,871

781,237

765,121

Restructuring

7,274

17,680

1,099

Operating earnings

71,408

86,461

157,996

199,241

Interest expense

16,685

19,896

34,608

40,137

Earnings before provision for income taxes

54,723

66,565

123,388

159,104

Provision for income taxes

13,862

19,757

32,190

43,458

Net earnings

$

40,861

$

46,808

$

91,198

$

115,646

Earnings per share:

Basic

$

0.38

$

0.43

$

0.85

$

1.05

Diluted

$

0.37

$

0.42

$

0.83

$

1.03

Weighted-average shares:

Basic

107,453

108,743

107,294

110,387

Diluted

109,706

110,540

109,499

112,207

The accompanying notes are an integral part of these condensed consolidated financial statements.

5


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

Three Months Ended

Six Months Ended

March 31,

March 31,

2023

2022

2023

2022

Net earnings

$

40,861

$

46,808

$

91,198

$

115,646

Other comprehensive income (loss):

Foreign currency translation adjustments

9,445

( 2,752

)

35,386

( 7,261

)

Interest rate caps, net of tax

( 2,163

)

( 1,960

)

278

Foreign exchange contracts, net of tax

( 1,017

)

( 324

)

( 1,927

)

156

Other comprehensive income (loss), net of tax

6,265

( 3,076

)

31,499

( 6,827

)

Total comprehensive income

$

47,126

$

43,732

$

122,697

$

108,819

The accompanying notes are an integral part of these condensed consolidated financial statements.

6


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

(In thousands)

(Unaudited)

Accumulated

Additional

Other

Total

Common Stock

Paid-in

Accumulated

Comprehensive

Stockholders’

Shares

Amount

Capital

Earnings

Loss

Equity

Balance at September 30, 2022

106,970

$

1,070

$

4,241

$

440,172

$

( 151,847

)

$

293,636

Net earnings

50,337

50,337

Other comprehensive income

25,234

25,234

Share-based compensation

5,135

5,135

Stock issued for equity awards

404

4

78

82

Employee withholding taxes paid

related to net share settlement

( 90

)

( 1

)

( 1,125

)

( 1,126

)

Balance at December 31, 2022

107,284

$

1,073

$

8,329

$

490,509

$

( 126,613

)

$

373,298

Net earnings

40,861

40,861

Other comprehensive income

6,265

6,265

Share-based compensation

3,838

3,838

Stock issued for equity awards

266

3

1,638

1,641

Employee withholding taxes paid

related to net share settlement

( 1

)

( 15

)

( 15

)

Balance at March 31, 2023

107,549

$

1,076

$

13,790

$

531,370

$

( 120,348

)

$

425,888

Accumulated

Additional

Other

Total

Common Stock

Paid-in

Accumulated

Comprehensive

Stockholders’

Shares

Amount

Capital

Earnings

Loss

Equity

Balance at September 30, 2021

112,913

$

1,129

$

17,286

$

356,967

$

( 94,641

)

$

280,741

Net earnings

68,838

68,838

Other comprehensive loss

( 3,751

)

( 3,751

)

Share-based compensation

3,958

3,958

Stock issued for equity awards

795

8

7,364

7,372

Employee withholding taxes paid

related to net share settlement

( 56

)

( 1

)

( 1,136

)

( 1,137

)

Repurchases and cancellations of

common stock

( 3,675

)

( 36

)

( 27,472

)

( 47,492

)

( 75,000

)

Balance at December 31, 2021

109,977

$

1,100

$

$

378,313

$

( 98,392

)

$

281,021

Net earnings

46,808

46,808

Other comprehensive loss

( 3,076

)

( 3,076

)

Share-based compensation

2,032

2,032

Stock issued for equity awards

111

1

423

424

Employee withholding taxes paid

related to net share settlement

( 1

)

( 15

)

( 15

)

Repurchases and cancellations of

common stock

( 3,157

)

( 32

)

( 2,440

)

( 52,856

)

( 55,328

)

Balance at March 31, 2022

106,930

$

1,069

$

$

372,265

$

( 101,468

)

$

271,866

The accompanying notes are an integral part of these condensed consolidated financial statements.

7


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Six Months Ended March 31,

2023

2022

Cash Flows from Operating Activities:

Net earnings

$

91,198

$

115,646

Adjustments to reconcile net earnings to net cash provided (used)

by operating activities:

Depreciation and amortization

50,347

48,471

Share-based compensation expense

8,973

5,990

Amortization of deferred financing costs

1,311

1,865

Loss on early extinguishment of debt

601

Impairment of long-lived assets, including operating lease assets

1,765

Loss on disposal of equipment and other property

2

80

Deferred income taxes

862

6,507

Changes in (exclusive of effects of acquisitions):

Trade accounts receivable

4,632

3,800

Accounts receivable, other

( 5,805

)

2,108

Inventory

( 68,355

)

( 95,468

)

Other current assets

6,053

( 6,273

)

Other assets

2,201

1,979

Operating leases, net

( 14,286

)

3,657

Accounts payable and accrued liabilities

108

( 70,217

)

Income taxes payable

434

( 8,393

)

Other liabilities

( 393

)

( 12,525

)

Net cash provided (used) by operating activities

79,648

( 2,773

)

Cash Flows from Investing Activities:

Payments for property and equipment, net of proceeds

( 42,181

)

( 44,109

)

Acquisitions, net of cash acquired

( 318

)

Net cash used by investing activities

( 42,181

)

( 44,427

)

Cash Flows from Financing Activities:

Proceeds from issuance of long-term debt

853,000

Repayments of long-term debt

( 898,093

)

( 2,841

)

Payments for common stock repurchased

( 130,328

)

Proceeds from equity awards

1,723

7,796

Debt issuance costs

( 4,726

)

Employee withholding taxes paid related to net share settlement of equity awards

( 1,141

)

( 1,151

)

Net cash used by financing activities

( 49,237

)

( 126,524

)

Effect of foreign exchange rate changes on cash and cash equivalents

2,832

178

Net decrease in cash and cash equivalents

( 8,938

)

( 173,546

)

Cash and cash equivalents, beginning of period

70,558

400,959

Cash and cash equivalents, end of period

$

61,620

$

227,413

Supplemental Cash Flow Information:

Interest paid

$

35,191

$

37,809

Income taxes paid

$

32,077

$

56,701

Capital expenditures incurred but not paid

$

5,466

$

3,205

The accompanying notes are an integral part of these condensed consolidated financial statements.


8


Sally Beauty Holdings, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1.

Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated interim financial statements of Sally Beauty Holdings, Inc. and its subsidiaries included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly our consolidated financial position as of March 31, 2023, and September 30, 2022, our consolidated results of operations, consolidated comprehensive income and consolidated statements of stockholders’ equity for the three and six months ended March 31, 2023 and 2022 and our consolidated cash flows for the for the six months ended March 31, 2023 and 2022 .

Principles of Consolidation

The unaudited condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. All amounts are in U.S. Dollars.

Accounting Policies

We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.

Use of Estimates

In order to present our financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable information available, however are subject to change in the future. Significant estimates and assumptions are part of our accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangibles and goodwill, and other reserves. We believe these estimates and assumptions are reasonable; however, they are based on management’s current knowledge of events and actions, and changes in facts and circumstances may result in revised estimates and impact actual results.

2.

Revenue Recognition

Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale. Revenue is recognized net of estimated sales returns and sales taxes. We estimate sales returns based on historical data.

Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, for the periods were as follows (in thousands):

Six Months Ended March 31,

2023

2022

Beginning Balance

$

13,460

$

16,744

Loyalty points and gift cards issued but not redeemed, net of estimated breakage

9,327

6,214

Revenue recognized from beginning liability

( 8,370

)

( 6,316

)

Ending Balance

$

14,417

$

16,642

See Note 10, Segment Reporting , for additional information regarding the disaggregation of our sales revenue.


9


3.

Fair Value Measurements

We measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC Topic 820, Fair Value Measurement, as amended (“ASC 820”). We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. This valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date.

The three levels of that hierarchy are defined as follows:

Level 1 - Quoted prices are available in active markets for identical assets or liabilities;

Level 2 - Pricing inputs are other than quoted prices in active markets, included in Level 1, that are either directly or indirectly observable; and

Level 3 - Unobservable pricing inputs in which little or no market activity exists, therefore requiring an entity to develop its own model with estimates and assumptions.

Financial instruments measured at fair value on recurring basis

Consistent with the fair value hierarchy, we categorized our financial assets and liabilities as follow:

(in thousands)

Classification

Fair Value Hierarchy Level

March 31,

2023

September 30,

2022

Financial Assets:

Foreign exchange contracts

Non-designated cash flow hedges

Other current assets

Level 2

$

327

$

294

Interest rate caps

Other current assets

Level 2

3,860

Total assets

$

327

$

4,154

.

Financial Liabilities:

Foreign exchange contracts

Designated cash flow hedges

Accrued liabilities

Level 2

$

2,300

$

Non-designated cash flow hedges

Accrued liabilities

Level 2

1,887

79

Total liabilities

$

4,187

$

79

The fair value for interest rate caps and foreign exchange contracts were measured using widely accepted valuation techniques, such as discounted cash flow analyses and observable inputs, such as market interest rates and foreign exchange rates.

Other fair value disclosures

The carrying amounts of cash equivalents, trade and other accounts receivable and accounts payable and borrowing under our ABL facility approximate their respective fair values due to the short-term nature of these financial instruments. Carrying amounts and the related estimated fair value of our long-term debt, excluding finance lease obligations, debt issuance costs and original issue discounts, are as follows:

March 31, 2023

September 30, 2022

(in thousands)

Fair Value Hierarchy Level

Carrying Value

Fair Value

Carrying Value

Fair Value

Long-term debt, excluding capital leases

Senior notes

Level 1

$

679,961

$

668,062

$

679,961

$

639,163

Term loan B due 2024

Level 2

407,500

398,331

Term loan B due 2030

Level 2

400,000

398,500

Total long-term debt

$

1,079,961

$

1,066,562

$

1,087,461

$

1,037,494

The fair value of the term loan B was measured using quoted market prices for similar debt securities in active markets or widely accepted valuation techniques, such as discounted cash flow analyses, using observable inputs, such as market interest rates.

10


4.

Stockholders’ Equity

Share Repurchases

In August 2017, our Board of Directors (“Board”) approved a share repurchase program authorizing us to repurchase up to $ 1.0 billion of its common stock, subject to certain limitations governed by our debt agreements. In July 2021, our Board approved a term extension of the share repurchase program for the four-year period ending September 30, 2025 . As of March 31, 2023, we had authorization of approximately $ 595.8 million of additional potential share repurchases remaining under our share repurchase program. For the three and six months ended March 31, 2023, we did no t repurchase shares under our share repurchase program. For the three and six months ended March 31, 2022, we repurchased 3.1 million and 6.8 million shares of common stock, respectively, at a total cost of $ 55.0 million and $ 130.3 million, respectively.

Accumulated Other Comprehensive Income (Loss)

The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):

Foreign Currency Translation Adjustments

Interest Rate Caps

Foreign Exchange Contracts

Total

Balance at September 30, 2022

$

( 153,128

)

$

1,960

$

( 679

)

$

( 151,847

)

Other comprehensive loss before

reclassification, net of tax

35,386

817

( 1,815

)

34,388

Reclassification to net earnings, net of tax

( 2,777

)

( 112

)

( 2,889

)

Balance at March 31, 2023

$

( 117,742

)

$

$

( 2,606

)

$

( 120,348

)

The tax impact for the changes in other comprehensive loss and the reclassifications to net earnings was not material.

5.

Weighted-Average Shares

The following table sets forth the reconciliation of basic and diluted weighted-average shares (in thousands):

Three Months Ended

March 31,

Six Months Ended

March 31,

2023

2022

2023

2022

Weighted-average basic shares

107,453

108,743

107,294

110,387

Dilutive securities:

Stock option and stock award programs

2,253

1,797

2,205

1,820

Weighted-average diluted shares

109,706

110,540

109,499

112,207

Anti-dilutive options excluded from our computation of diluted shares

1,964

2,534

1,964

2,169

6.

Goodwill and Intangible Assets

During the three months ended March 31, 2023, we completed our annual assessments for impairment of goodwill and indefinite-lived intangible assets. For our goodwill testing, we performed a qualitative analysis and determined that there was no indication of impairment requiring further quantitative testing. No material impairment losses were recognized in the current or prior periods presented in connection with our goodwill and intangible assets.

Three Months Ended

March 31,

Six Months Ended

March 31,

(in thousands)

2023

2022

2023

2022

Intangible assets amortization expense

$

866

$

999

$

1,875

$

2,070

Additionally, during the six months ended March 31, 2023, the changes in goodwill and other intangibles included effects of foreign currency exchange rates of $ 8.2 million and $ 2.1 million, respectively.

11


7.

Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

March 31,

2023

September 30,

2022

Compensation and benefits

$

66,868

$

58,693

Deferred revenue

18,980

18,810

Rental obligations

12,766

10,701

Insurance reserves

6,111

5,742

Property and other taxes

3,022

4,161

Interest payable

13,699

13,445

Operating accruals and other

46,741

49,513

Total accrued liabilities

$

168,187

$

161,065

8.

Short-term Borrowings and Long-term Debt

At March 31, 2023, our ABL facility had $ 34.0 million in outstanding borrowings and $ 448.7 million available for borrowing, including the Canadian sub-facility, subject to borrowing base limitation, as reduced by outstanding letters of credit .

On February 28, 2023, we announced that our wholly-owned subsidiaries, Sally Holdings LLC (“Sally Holdings”) and Sally Capital, Inc. (“Sally Capital” and, together with Sally Holdings, the “Borrowers”), and certain of our other direct and indirect subsidiaries entered into a credit agreement with Bank of America, N.A., as Administrative Agent and Collateral Agent, and the lenders and other parties thereto providing for a term loan B facility (“TLB 2030”) in an aggregate principal amount equal to $ 400.0 million, the net proceeds of which were used to repay an existing term loan B facility (“TLB 2024”). The TLB 2030 will bear interest at a floating rate equal to, at the Borrowers option, either the Adjusted Term SOFR Rate from time to time in effect plus 2.50 % or an adjusted base rate plus 1.50 %, payable quarterly on March 31, June 30, September 30 and December 31 of each year. The TLB 2030 matures on the earlier of (i) February 28, 2030 and (ii) the date that is 91 days prior to the stated maturity of the Borrowers’ 2025 Senior Unsecured Notes (the “2025 Senior Unsecured Notes”) unless all amounts exceeding $ 200.0 million of the 2025 Senior Unsecured Notes are refinanced or repaid according to certain conditions (the “Maturity Date”). The principal of the TLB 2030 is repayable in quarterly installments equal to 0.25 % of the original principal amount of the TLB 2030, with a final installment equal to the entire remaining outstanding principal amount due on the Maturity Date . TLB 2030 was issued at a discount of 0.75 % and we incurred $ 4.7 million in issuance costs; both of which are being amortized using the effective interest method.

The TLB 2030 is secured by a first-priority lien in and upon substantially all of the assets of the Company and its domestic subsidiaries other than the accounts, inventory (and the proceeds thereof) and other assets that secure Sally Holdings’ existing ABL facility on a first-priority basis (the “ABL Priority Collateral”). Additionally, the TLB 2030 is secured by a second-priority lien in and upon the ABL Priority Collateral. The TLB 2030 does not contain any financial maintenance covenants and is subject to a covenant package that is substantially consistent with the covenant package governing the 2025 Senior Unsecured Notes. The TLB 2030 is subject to customary asset sale mandatory prepayment provisions and excess cash flow mandatory prepayment provisions. The TLB 2030 is subject to a prepayment premium of 1.0 % of the principal amount thereof upon any refinancing or amendment thereof that results in a reduced effective yield (subject to certain exceptions) within six months following the closing. Thereafter, the TLB 2030 may be prepaid without penalty or premium, other than customary breakage costs for prepayments that are made prior to the last date of an interest period.

The repayment of our TLB 2024, in the aggregate outstanding principal amount of $ 406.1 million, was made pursuant to the terms of the indenture dated February 28, 2017 , at par plus interest accrued but unpaid up to, though not including, the repayment date. In connection with the repayment, we recognized a loss on the extinguishment of debt of $ 0.6 million within interest expense, which included the write-off of unamortized discount and deferred financing costs of $ 0.2 million and $ 0.4 million, respectively.


12


9.

Derivative Instruments and Hedging Activities

During the six months ended March 31, 2023, we did no t purchase or hold any derivative instruments for trading or speculative purposes. See Note 3, Fair Value Measurements , for the classification and fair value of our derivative instruments.

Designated Cash Flow Hedges

Foreign Currency Forwards

We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on forecasted inventory purchases in U.S. dollars by our foreign subsidiaries. At March 31, 2023, we held forwards, which expire ratably through September 30, 2023 , with a notional amount, based upon exchange rates at March 31, 2023, as follows (in thousands):

Notional Currency

Notional Amount

Mexican Peso

$

12,846

Euro

7,699

Canadian Dollar

6,284

Total

$

26,829

Quarterly, the changes in fair value related to these foreign currency forwards are recorded into AOCL. As the forwards are exercised, the realized value is recognized into cost of goods sold, based on inventory turns, in our condensed consolidated statements of earnings. For the three months ended March 31, 2023 and 2022, we recognized losses of $ 0.2 million and $ 0.1 million, respectively. For the six months ended March 31, 2023 and 2022, we recognized a gain of $ 0.1 million and a loss of $ 0.4 million, respectively. Based on March 31, 2023, valuations and exchange rates, we expect to reclassify losses of approximately $ 3.1 million into cost of goods sold over the next 12 months.

Interest Rate Caps

In July 2017, we purchased two interest rate caps with an initial aggregate notional amount of $ 550 million (the “interest rate caps”) to mitigate the exposure to higher interest rates in connection with our TLB 2024. The interest rate caps were comprised of individual caplets that were expiring ratably through June 30, 2023 , and were designated as cash flow hedges. Accordingly, the changes in fair value of the interest rate caps were recorded quarterly, net of income tax, and included in AOCL.

During the three months ended March 31, 2023, we early settled both interest rate caps due to the forecasted transactions being hedged no longer occurring as a result of the repayment of our TLB 2024. In connection with the early settlement, we received approximately $ 2.7 million, which represented the fair value at the time of settlement. Furthermore, we released the remaining AOCL balances related to the interest rate caps into interest expense. For the three months ended March 31, 2023, we recognized income of $ 2.8 million into interest expense on our condensed consolidated statements of earnings related to the caps. The effects of our interest rate caps on our condensed consolidated statements of earnings were not material for the three months ended March 31, 2022. For the six months ended March 31, 2023 and 2022, we recognized income of $ 2.8 million and expense of $ 0.4 million, respectively, into interest expense on our condensed consolidated statements of earnings related to the caps.

Non-Designated Derivative Instruments

We also use foreign exchange contracts to mitigate our exposure to exchange rate changes in connection with certain intercompany balances not permanently invested. At March 31, 2023, we held forwards, which expire on various dates in the first month of both the third and fourth fiscal quarters of fiscal year 2023, with a notional amount, based upon exchange rates at March 31, 2023, as follows (in thousands):

Notional Currency

Notional Amount

British Pound

$

51,936

Canadian Dollar

13,491

Euro

21,173

Mexican Peso

26,175

Total

$

112,775

We record changes in fair value and realized gains or losses related to these foreign currency forwards into selling, general and administrative expenses. For the three months ended March 31, 2023 and 2022, the effects of these foreign exchange contracts on our condensed consolidated financial statements were losses of $ 1.5 million and $ 0.2 million, respectively. For the six months ended March 31, 2023 and 2022, the effects of these foreign exchange contracts on our condensed consolidated financial statements were a loss of $ 1.1 million and a gain of $ 0.1 million, respectively.

13


10.

Segment Reporting

Segment data for the three and six months ended March 31, 2023 and 2022, is as follows (in thousands):

Three Months Ended

March 31,

Six Months Ended

March 31,

2023

2022

2023

2022

Net sales:

Sally Beauty Supply ("SBS")

$

530,246

$

525,785

$

1,079,718

$

1,087,315

Beauty Systems Group ("BSG")

388,466

385,602

796,049

804,323

Total

$

918,712

$

911,387

$

1,875,767

$

1,891,638

Earnings before provision for income taxes:

Segment operating earnings:

SBS

$

92,134

$

80,940

$

191,308

$

181,563

BSG

37,260

46,008

86,907

104,554

Segment operating earnings

129,394

126,948

278,215

286,117

Unallocated expenses

50,712

40,487

102,539

85,777

Restructuring

7,274

17,680

1,099

Consolidated operating earnings

71,408

86,461

157,996

199,241

Interest expense

16,685

19,896

34,608

40,137

Earnings before provision

for income taxes

$

54,723

$

66,565

$

123,388

$

159,104

Sales between segments, which are eliminated in consolidation, were not material during the three and six months ended March 31, 2023 and 2022.

Disaggregation of net sales by segment

The following tables disaggregate our segment revenues by merchandise category. We have reclassified certain prior year amounts within BSG to conform to current year presentation.

Three Months Ended

March 31,

Six Months Ended

March 31,

SBS

2023

2022

2023

2022

Hair color

39.8

%

38.1

%

39.2

%

37.4

%

Hair care

24.3

%

24.1

%

23.9

%

24.0

%

Styling tools and supplies

17.9

%

19.2

%

18.7

%

19.7

%

Nail

10.0

%

10.6

%

10.2

%

10.5

%

Skin and cosmetics

7.5

%

7.4

%

7.4

%

7.7

%

Other beauty items

0.5

%

0.6

%

0.6

%

0.7

%

Total

100.0

%

100.0

%

100.0

%

100.0

%

Three Months Ended

March 31,

Six Months Ended

March 31,

BSG

2023

2022

2023

2022

Hair care

42.0

%

43.1

%

42.8

%

43.3

%

Hair color

40.6

%

39.5

%

39.4

%

38.9

%

Styling tools and supplies

10.8

%

11.2

%

10.8

%

11.3

%

Skin and cosmetics

3.7

%

3.5

%

4.1

%

3.9

%

Nail

2.7

%

2.3

%

2.7

%

2.2

%

Other beauty items

0.2

%

0.4

%

0.2

%

0.4

%

Total

100.0

%

100.0

%

100.0

%

100.0

%

14


The following tables disaggregate our segment revenue by sales channels:

Three Months Ended

March 31,

Six Months Ended

March 31,

SBS

2023

2022

2023

2022

Company-operated stores

93.6

%

93.7

%

93.6

%

94.0

%

E-commerce

6.4

%

6.3

%

6.4

%

6.0

%

Total

100.0

%

100.0

%

100.0

%

100.0

%

Three Months Ended

March 31,

Six Months Ended

March 31,

BSG

2023

2022

2023

2022

Company-operated stores

67.5

%

66.6

%

66.9

%

67.1

%

E-commerce

13.7

%

12.4

%

13.7

%

12.0

%

Distributor sales consultants

11.4

%

14.0

%

12.0

%

13.8

%

Franchise stores

7.4

%

7.0

%

7.4

%

7.1

%

Total

100.0

%

100.0

%

100.0

%

100.0

%

11.

Restructuring

Restructuring expenses, included in Cost of Goods Sold (“COGS”) and Restructuring for the three and six months ended March 31, 2023 and 2022 are as follows (in thousands):

Three Months Ended

March 31,

Six Months Ended

March 31,

2023

2022

2023

2022

Included in COGS (a)

Distribution Center Consolidation

and Store Optimization Plan

$

( 2,362

)

$

$

( 5,042

)

$

Included in Restructuring (b)

Distribution Center Consolidation

and Store Optimization Plan

$

7,274

$

$

17,680

$

Transformation Plan

1,099

Total in Restructuring

7,274

17,680

1,099

Total Restructuring Expenses

$

4,912

$

$

12,638

$

1,099

(a)

Amounts included within COGS are related to adjustments to our expected obsolescence reserve related to the Plan (as defined below).

(b)

Amounts included within Restructuring for the current year are related to stores and distribution centers closed during the period in accordance with the Plan (as defined below).

Distribution Center Consolidation and Store Optimization Plan

In the fourth quarter of fiscal year 2022, our Board approved the Distribution Center Consolidation and Store Optimization Plan (“the Plan”) authorizing the closure of 330 SBS stores and 35 BSG stores, and the closure of two BSG distribution centers in Clackamas, Oregon and Pottsville, Pennsylvania.

We believe that consolidating the operation of these two distribution centers into our larger distribution centers will increase product availability, shorten delivery times and reduce overall costs. Stores identified for early closure were part of a strategic evaluation which included a market analysis of certain locations where we believe we will be able to recapture demand at other nearby store locations and improve overall profitability. By optimizing our store base, we are further focusing on our customers’ shopping experience and our product offerings.

As of March 31, 2023, we have closed 329 SBS stores and 28 BSG stores as part of the Plan and closed the two BSG distributions centers. The Plan will continue to be executed throughout fiscal year 2023 and into the first half of fiscal year 2024, and therefore it may include future charges related to store closures such as exit costs, lease negotiation penalties, termination benefits and adjustments to estimates.

15


The liability related to the Plan, which is included in accounts payable and accrued liabilities on our consolidated balance sheets, is as follows:

(in thousands)

Liability at

September 30,

2022

SBS Expense

BSG Expense

Cash Payments

Non-Cash Amounts

Liability at

March 31,

2023

Closing costs - leases (a)

$

$

7,389

$

1,307

$

( 5,463

)

$

( 1,043

)

$

2,190

Closing costs - payroll expenses (b)

1,540

979

( 2,458

)

61

Impairment - property and equipment (c)

1,276

193

( 1,469

)

Inventory transfer costs

1,158

322

( 1,372

)

108

Impairment - operating lease assets (c)

350

244

( 594

)

Other closure costs (d)

1,291

2,978

( 56

)

( 2,659

)

1,554

Total

$

1,291

$

14,691

$

2,989

$

( 11,952

)

$

( 3,106

)

$

3,913

(a)

Lease-related closing costs include contract terminations costs, repairs, maintenance, and other rental obligations associated with closing stores.

(b)

Payroll-related closing costs include one-time termination benefits related to the closure of our distribution centers as well as other payroll expenses associated with closing stores.

(c)

Remaining carrying value for the long-lived assets, including operating lease assets, were not material and approximate their fair value.

(d)

Other closure costs predominantly consist of exit costs associated with shutting down of operations at various locations.

12.

Subsequent Event

In April 2023, we entered into an interest rate swap transaction to help mitigate the risk of our floating rate debt. The notional amount of the swap is $ 200 million with an effective date of April 28, 2023 and a termination date of April 30, 2026 . Under the terms of the swap, we will pay a fixed rate of interest of 3.705 % and will receive a floating rate of interest equal to one-month SOFR. The floating rate will be reset monthly and net settlements of interest due to/from the counterparty will also occur monthly. To the extent the floating rate of interest exceeds the fixed rate of interest, we will receive net interest settlements, which will be recorded as a reduction to interest expense. If the fixed rate of interest exceeds the floating rate of interest, we will be required to pay net settlements to the counterparty and will record those net payments in interest expense .

16


Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

This section discusses management’s view of the financial condition, results of operations and cash flows of Sally Beauty for the periods covered by this Quarterly Report. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, including the Risk Factors sections therein, and information contained elsewhere in this Quarterly Report, including the condensed consolidated interim financial statements and notes to those financial statements.

Executive Overview

For fiscal 2023, we are focusing on three key strategic initiatives to drive growth and profitability:

Enhancing our customer centricity;

Growing high margin owned brands at Sally Beauty and amplifying innovation; and

Increasing the efficiency of our operations and optimizing our capabilities.

We believe focusing in these areas will position our company for future growth and further enhance our ability to meet our customers where they are.

Enhancing our customer centricity

During the fiscal year, SBS launched its first Studio by Sally pilot store in Denton, Texas and has identified other locations for its additional pilot stores expected to open this fiscal year. The Studio by Sally pilot store program will have a digital-first focus, from digital check-in to digital education throughout the store and beyond, including personalized appointments at our in-store salons with licensed stylists who will train and educate consumers on how to personally achieve their desired results. We believe that we will be able to expand the Studio by Sally concept to 100 locations throughout the U.S. over the next three to four fiscal years if successful.

Additionally, earlier this fiscal year, BSG launched a new strategic partnership with Salon HQ to help its professional stylist customers grow their business. Salon HQ is a customizable digital storefront platform that gives stylists the ability to curate a product selection from thousands of BSG merchandise choices, and enables their clients to purchase directly from their shops without the stylists having to finance and carry inventory.

Growing high margin owned brands at Sally Beauty and amplifying innovation

We believe growing our SBS owned brands, through innovation and marketing, will provide improved margins, strengthen our long-term relationships with existing customers and help attract new customers. During the fiscal year, we have invested more into marketing of our owned brands and launched the first and second phases of our new owned branded vegan hair repair product line – bondbar – that’s SLS/SLES-free, paraben-free, phthalate-free and cruelty-free. These initiatives delivered an increase in our owned brands sales penetration, resulting in increased SBS profit margins.

Furthermore during the second quarter, some of our BSG vendors began launching new and exciting product lines, including Paul Mitchell’s new permanent hair color line for gray coverage – the color 10 – that is a formulated using sustainably sourced beeswax, and Wella’s new hair care line – Ultimate Repair – which helps nourish and repair damaged hair. We are thrilled to be able to provide these new innovative products to salons and stylists, and look forward to providing more of our BSG vendor’s new innovative products in our third quarter.

Increasing the efficiency of our operations and optimizing our capabilities

At the end of fiscal year 2022, we announced our plan to close 330 SBS stores, 35 BSG stores and two BSG distribution centers. Based on our strategic evaluation, we believe that we will able to recapture approximately half of the demand of closed stores in other nearby store locations and improve overall profitability. During the first quarter, we completed the closure of our two BSG distributions centers and the majority of our planned store closures. Additionally, we have re-optimized our store supply chain network based on our new store fleet. As of March 31, 2023, we have closed 329 SBS stores and 28 BSG stores as part of the Plan and are currently meeting our sales recapture expectations.

See Note 11, Restructuring , in Item 1 of this quarterly report for more information on the Plan.

Financial Summary for the Three Months Ended March 31, 2023

Consolidated net sales for the three months ended March 31, 2023, increased $7.3 million, or 0.8%, to $918.7 million, compared to the three months ended March 31, 2022. Consolidated net sales included a negative impact from changes in foreign currency exchange rates of $7.0 million;

Consolidated comparable sales increased 5.7% for the three months ended March 31, 2023;

17


Consolidated gross profit for the three months ended March 31, 2023, increased $3.0 million, or 0.6%, to $468.3 million, compared to the three months ended March 31, 2022. Consolidated gross margin decreased 10 bps to 51.0% for the three months ended March 31, 2023, compared to the three months ended March 31, 2022;

Consolidated operating earnings for the three months ended March 31, 2023, decreased $15.1 million, or 17.4%, to $71.4 million, compared to the three months ended March 31, 2022. Operating margin decreased 170 bps to 7.8% for the three months ended March 31, 2023, compared to the three months ended March 31, 2022;

For the three months ended March 31, 2023, our consolidated net earnings decreased $5.9 million, or 12.7%, to $40.9 million, compared to the three months ended March 31, 2022;

For the three months ended March 31, 2023, our diluted earnings per share was $0.37 compared to $0.42 for the three months ended March 31, 2022;

Cash provided by operations was $24.7 million for the three months ended March 31, 2023, compared to $2.9 million for the three months ended March 31, 2022; and

On February 28, 2023, we entered into a seven-year term loan B facility agreement, with an aggregate principal amount equal to $400.0 million, and used the funds to repay our previously existing term loan B facility.

Trends Impacting Our Business

Global inflationary pressures continue to influence consumer and stylist behavior along with the cost for products and services. In the U.S. and Canada, we are seeing our SBS customers color their hair less frequently and reduce the size of their basket when they shop with us, while at BSG we are seeing stylists purchasing closer to the time they use products. Additionally, inflationary pressures have impacted wages, especially among retail and hourly employees, as we have experienced an increase in our labor costs in order to attract and retain associates. During the current year, these headwinds have resulted in lower traffic and conversion in our business and increases in certain operating costs. We continue to monitor these challenges and implement measures to help mitigate their impacts, including managing our inventory levels to reduce out-of-stock items, adjusting our promotional activities, optimizing our store base and expanding our partnerships with delivery service providers. Although these initiatives have helped mitigate ongoing macro-headwinds, we cannot reasonably predict the long-term effects of inflation.

Furthermore, in a measure to curb inflation, the U.S. Federal Reserve has increased the federal funds effective rate. In turn, these increases have raised the cost of debt borrowings. We currently have $434.0 million in variable rate debt outstanding and future increases in the federal funds effective rate could have a material adverse impact to our cost of borrowing, including any future changes in our debt structure.

Comparable Sales

We believe that comparable sales is an appropriate performance indicator to measure our sales growth compared to the prior period. O ur comparable sales include sales from stores that have been operating for 14 months or longer as of the last day of a month and e-commerce revenue. Additionally, comparable sales include sales to franchisees and full service sales. Our comparable sales excludes the effect of changes in foreign exchange rates and sales from stores relocated until 14 months after the relocation. Revenue from acquisitions are excluded from our comparable sales calculation until 14 months after the acquisition. Our calculation of comparable sales might not be the same as other retailers as the calculation varies across the retail industry.


18


Overview

Key Operating Metrics

The following table sets forth, for the periods indicated, information concerning key measures we rely on to evaluate our operating performance (dollars in thousands):

Three Months Ended

March 31,

Six Months Ended

March 31,

2023

2022

Increase (Decrease)

2023

2022

Increase (Decrease)

Net sales:

SBS

$

530,246

$

525,785

$

4,461

0.8

%

$

1,079,718

$

1,087,315

$

(7,597

)

(0.7

)%

BSG

388,466

385,602

2,864

0.7

%

796,049

804,323

(8,274

)

(1.0

)%

Consolidated

$

918,712

$

911,387

$

7,325

0.8

%

$

1,875,767

$

1,891,638

$

(15,871

)

(0.8

)%

Gross profit:

SBS

$

317,117

$

309,262

$

7,855

2.5

%

$

640,592

$

637,434

$

3,158

0.5

%

BSG

151,222

156,070

(4,848

)

(3.1

)%

316,321

328,027

(11,706

)

(3.6

)%

Consolidated

$

468,339

$

465,332

$

3,007

0.6

%

$

956,913

$

965,461

$

(8,548

)

(0.9

)%

Segment gross margin:

SBS

59.8

%

58.8

%

100

bps

59.3

%

58.6

%

70

bps

BSG

38.9

%

40.5

%

(160)

bps

39.7

%

40.8

%

(110)

bps

Consolidated

51.0

%

51.1

%

(10)

bps

51.0

%

51.0

%

bps

Net earnings:

Segment operating earnings:

SBS

$

92,134

$

80,940

$

11,194

13.8

%

$

191,308

$

181,563

$

9,745

5.4

%

BSG

37,260

46,008

(8,748

)

(19.0

)%

86,907

104,554

(17,647

)

(16.9

)%

Segment operating earnings

129,394

126,948

2,446

1.9

%

278,215

286,117

(7,902

)

(2.8

)%

Unallocated expenses and restructuring (a)

57,986

40,487

17,499

43.2

%

120,219

86,876

33,343

38.4

%

Consolidated operating earnings

71,408

86,461

(15,053

)

(17.4

)%

157,996

199,241

(41,245

)

(20.7

)%

Interest expense

16,685

19,896

(3,211

)

(16.1

)%

34,608

40,137

(5,529

)

(13.8

)%

Earnings before provision for income taxes

54,723

66,565

(11,842

)

(17.8

)%

123,388

159,104

(35,716

)

(22.4

)%

Provision for income taxes

13,862

19,757

(5,895

)

(29.8

)%

32,190

43,458

(11,268

)

(25.9

)%

Net earnings

$

40,861

$

46,808

$

(5,947

)

(12.7

)%

$

91,198

$

115,646

$

(24,448

)

(21.1

)%

.

Number of stores at end-of-period (including franchises) (b) :

SBS

3,143

3,499

(356

)

(10.2

)%

BSG

1,341

1,363

(22

)

(1.6

)%

Consolidated

4,484

4,862

(378

)

(7.8

)%

Comparable sales growth (decline):

SBS

9.1

%

(0.5

)%

960

bps

6.0

%

2.0

%

400

bps

BSG

1.3

%

1.3

%

bps

(0.2

)%

4.9

%

(510)

bps

Consolidated

5.7

%

0.2

%

550

bps

3.3

%

3.2

%

10

bps

(a)

Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings.

(b)

Our March 31, 2023 store count was impacted by store closure in connection with the Plan. See Note 11, Restructuring , in Item 1 of this quarterly report for more information on the Plan.


19


Results of Operations

The Three Months Ended March 31, 2023, compared to the Three Months Ended March 31, 2022

Net Sales

SBS . The increase in net sales for SBS was primarily driven by the following (in thousands):

Comparable sales

$

43,868

Sales outside comparable sales (a)

(34,456

)

Foreign currency exchange

(4,951

)

Total

$

4,461

(a)

Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months

The increase in SBS’s comparable sales was a result of a growth in our average unit retail, primarily from inflationary impacts and pricing leverage, and an increase in transactions, driven by recapturing approximately half of the sales from stores closed in connection with the Plan and the lapping of the prior year’s impact from Omicron and supply chain challenges .

BSG . The increase in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales

$

4,769

Sales outside comparable sales (a)

171

Foreign currency exchange

(2,076

)

Total

$

2,864

(a)

Includes stores opened for less than 14 months, net of stores closures, including stores closed under the Plan

BSG’s comparable sales reflected the lapping of the prior year’s impact from supply challenges and Omicron, partially offset by the impacts of the current economic environment on stylist shopping behaviors . These impacts resulted in an increase in our average unit retail and fewer units per transaction.

Gross Profit

SBS . SBS’s gross profit increased for the three months ended March 31, 2023, as a result of an increase in net sales and a higher gross margin. SBS’s gross margin grew as a result of pricing leverage, increased penetration of our owned brand products and adjustments to our expected obsolescence reserve related to the Plan.

BSG . BSG’s gross profit decreased for the three months ended March 31, 2023, as a result of a lower gross margin, partially offset by an increase in net sales. BSG’s gross margin decline was driven by lower product margin resulting from an unfavorable sales channel mix, between stores and lower-margin Regis e-commerce sales, and a shift in some distribution center costs from selling, general and administrative expenses into gross margin.

Selling, General and Administrative Expenses

SBS . SBS’s selling, general and administrative expenses decreased $3.3 million, or 1.5%, for the three months ended March 31, 2023 and included a favorable impact from foreign exchange rates of $2.2 million. As a percentage of SBS net sales, SG&A for the three months ended March 31, 2023 was 42.4% compared to 43.4% for the three months ended March 31, 2022. The decrease as a percentage of sales was primarily driven by cost savings from the closure of stores as part of the Plan, partially offset by increased labor and personnel costs and higher advertising expense.

BSG . BSG’s selling, general and administrative expenses increased $3.9 million, or 3.5%, for the three months ended March 31, 2023. As a percentage of BSG net sales, SG&A for the three months ended March 31, 2023 was 29.3% compared to 28.5% for the three months ended March 31, 2022. The increase as a percentage of sales was driven primarily by increases in labor and personnel costs.

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $10.2 million, or 25.3%, for the three months ended March 31, 2023, primarily due to increased labor and personnel costs and information technology expense .

Restructuring

For the three months ended March 31, 2023, we incurred $7.3 million in restructuring charges related to our Distribution Center Consolidation and Store Optimization Plan. See Note 11, Restructuring , in Item 1 of this quarterly report for more information on the Plan.

20


Interest Expense

The decrease in interest expense is due to the interest savings from the repayment of our 8.75% Senior Notes due 2025 in fiscal year 2022, partially offset by higher interest expense on our variable rate debt resulting from the increase in borrowing rates and outstanding amounts under our ABL facility . Additionally, we released the $2.2 million in net gains held in AOCL related to our interest rate caps due to the early settlement of the derivatives driven by the repayment of our TLB 2024.

Provision for Income Taxes

The effective tax rates were 25.3% and 29.7%, for the three months ended March 31, 2023, and 2022, respectively. The decrease in the effective tax rate was primarily due to the tax impact of share-based compensation which was beneficial this quarter, but detrimental in the prior year quarter, and greater losses in the prior year quarter for which a tax benefit could not be recognized.

The Six Months Ended March 31, 2023, compared to the Six Months Ended March 31, 2022

Net Sales

SBS . The decrease in net sales for SBS was primarily driven by the following (in thousands):

Comparable sales

$

59,822

Sales outside comparable sales (a)

(50,676

)

Foreign currency exchange

(16,743

)

Total

$

(7,597

)

(a)

Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months

SBS’s comparable sales increase was driven by a growth in our average unit retail, primarily from inflationary impacts, pricing leverage and the lapping of Omicron and supply chain challenges. Comparable sales were also positively impacted by recapturing of approximately half of the sales from stores closed in connection with the Plan.

BSG . The decrease in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales

$

(1,340

)

Sales outside comparable sales (a)

(2,225

)

Foreign currency exchange

(4,709

)

Total

$

(8,274

)

(a)

Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months

BSG’s comparable sales faced headwinds from elevated demand in the prior year from the easing of COVID-19 restrictions and the impacts of the current economic environment which resulted in fewer transactions and units per transaction, partially offset by an increase in our average unit retail.

Gross Profit

SBS . SBS’s gross profit increased for the six months ended March 31, 2023, as a result of a higher gross margin, partially offset by lower net sales. SBS’s gross margin grew as a result of pricing leverage, increased penetration of our owned brand products and adjustments to our expected obsolescence reserve related to the Plan.

BSG . BSG’s gross profit decreased for the six months ended March 31, 2023, as a result of lower net sales and a lower gross margin. BSG’s gross margin decline was driven by lower product margin resulting from an unfavorable sales channel mix, between stores and lower-margin Regis e-commerce sales, and a shift in some distribution center costs from selling, general and administrative expenses into gross margin, partially offset by adjustments to our expected obsolescence reserve related to the Plan.

Selling, General and Administrative Expenses

SBS . SBS’s selling, general and administrative expenses decreased $6.6 million, or 1.4%, for the six months ended March 31, 2023 and included a favorable impact from foreign exchange rates of $6.8 million. As a percentage of SBS net sales, SG&A for the six months ended March 31, 2023 was 41.6% compared to 41.9% for the six months ended March 31, 2022. The decrease as a percentage of sales was primarily driven by cost savings from the closure of stores in connection with the Plan, partially offset by an increase in labor and personnel costs.

BSG . BSG’s selling, general and administrative expenses increased $5.9 million, or 2.7%, for the six months ended March 31, 2023. As a percentage of BSG net sales, SG&A for the six months ended March 31, 2023 was 28.8% compared to 27.8% for the six months ended March 31, 2022. The increase as a percentage of sales was driven primarily by deleveraging as a result of lower net sales as well as increases in labor and personnel costs.

21


Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $16.8 million , or 19.5% , for the six months ended March 31, 2023 , primarily due to increased labor and personnel costs and information technology expenses .

Restructuring

For the six months ended March 31, 2023, we incurred $17.7 million in restructuring charges related to the Plan. For the six months ended March 31, 2022, restructuring charges in connection with our prior transformation plan were immaterial . See Note 11, Restructuring , in Item 1 of this quarterly report for more information on the Plan.

Interest Expense

The decrease in interest expense is due to interest savings from the repayment of our 8.75% Senior Notes due 2025 in fiscal year 2022, partially offset by higher interest expense on our variable rate debt resulting from the increase in borrowing rates and outstanding amounts under our ABL facility . Additionally, we released the $2.2 million in net gains held in AOCL related to our interest rate caps due to the early settlement of the derivatives driven by the repayment of our TLB 2024 in our second fiscal quarter.

Provision for Income Taxes

The effective tax rates were 26.1% and 27.3%, for the six months ended March 31, 2023, and 2022, respectively. The decrease in the effective tax rate was primarily due to greater losses in the prior year for which a tax benefit could not be recognized.

Liquidity and Capital Resources

Overview

Our principal sources of liquidity are from cash and cash equivalents, cash from operations and our ABL facility. A substantial portion of our liquidity needs arise from funding the costs of our operations, working capital, capital expenditures, debt interest and principal payment. Additionally, under our share repurchase program, see below for more details, we will from time-to-time repurchase shares of our common stock on the open market to return value to our shareholders. At March 31, 2023, we had $510.3 million in our liquidity pool, which includes $448.7 million available for borrowings under our ABL facility and cash and cash equivalents of $61.6 million.

Working capital (current assets less current liabilities) increased $113.9 million, to $578.4 million at March 31, 2023, compared to $464.5 million at September 30, 2022. This increase was driven by higher inventory balances, resulting from inflationary cost increases and the impact of foreign exchange rates of $21.7 million, and a decrease in borrowing outstanding under our ABL facility.

We anticipate that existing cash balances (excluding certain amounts permanently invested in connection with foreign operations), cash expected to be generated by operations, and funds available under our ABL facility will be sufficient to fund our working capital and capital expenditure requirements over the next twelve months.

Cash Flows

Six Months Ended March 31,

(in thousands)

2023

2022

Net cash provided (used) by operating activities

$

79,648

$

(2,773

)

Net cash used by investing activities

(42,181

)

(44,427

)

Net cash used by financing activities

(49,237

)

(126,524

)

Net Cash Provided (Used) by Operating Activities

The change in net cash provided by operating activities for the six months ended March 31, 2023, compared to the net cash used by operating activities for the six months ended March 31, 2022, was driven by the timing of inventory purchases and vendor payments, primarily from the impact of global supply chain issues in the prior year, and the decrease in net sales.

Net Cash Used by Investing Activities

The decrease in net cash used by investing activities for the six months ended March 31, 2023, compared to the six months ended March 31, 2022, was driven by fewer capital expenditures related to store improvements and information technology.

Net Cash Used by Financing Activities

The decrease in net cash used by financing activities for the six months ended March 31, 2023, compared to the six months ended March 31, 2022, was primarily a result of no share repurchases in the current year and the net reduction in our outstanding debt principal.

22


Debt and Guarantor Financial Information

On February 28, 2023, we entered into a seven-year term loan facility agreement in the aggregate principal amount of $400.0 million and used the proceeds to subsequently repay our previously existing term loan facility. See Note 8, Short-term Borrowings and Long-term Debt , in Item 1 of this quarterly report for more information.

At March 31, 2023, we had $1,114.0 million in outstanding debt, not including capital leases, unamortized debt issuance costs and debt discounts, in the aggregate, of $10.7 million. Our debt consists of $680.0 million in 2025 Senior Notes outstanding, $400.0 million remaining on our term loan and $34.0 million in outstanding borrowings under our ABL facility.

We utilize our ABL facility for the issuance of letters of credit, certain working capital and liquidity needs, and to manage normal fluctuations in our operational cash flow. In that regard, we may from time to time draw funds under the ABL facility for general corporate purposes including funding of capital expenditures, acquisitions, paying down other debt and share repurchases. Amounts drawn on our ABL facility are generally paid down with cash provided by our operating activities. During the six months ended March 31, 2023, the weighted average interest rate on our borrowings under the ABL facility was 5.5%.

We are currently in compliance with the agreements and instruments governing our debt, including our financial covenants.

Guarantor Financial Information

Our 2025 Senior Notes were issued by our wholly-owned subsidiaries, Sally Holdings LLC and Sally Capital Inc. (the “Issuers”). The notes are unsecured debt instruments guaranteed by us and certain of our wholly-owned domestic subsidiaries (together, the “Guarantors”) and have certain restrictions on the ability of our subsidiaries to make certain restrictive payments to Sally Beauty. The guarantees are joint and several, and full and unconditional. Certain other subsidiaries, including our foreign subsidiaries, do not serve as guarantors.

The following summarized consolidating financial information represents financial information for the Issuers and the Guarantors on a combined basis. All transactions and intercompany balances between these combined entities has been eliminated.

The following table presents the summarized balance sheets information for the Issuers and the Guarantors as of March 31, 2023, and September 30, 2022:

(in thousands)

March 31, 2023

September 30, 2022

Inventory

$

768,531

$

714,477

Intercompany receivable

$

5,287

$

Current assets

$

879,479

$

827,155

Total assets

$

2,032,568

$

1,982,982

Current liabilities

$

517,349

$

549,415

Intercompany payable

$

$

4,431

Total liabilities

$

2,046,853

$

2,085,169

The following table presents the summarized statement of earnings information for the Issuers and the Guarantors for six months ended March 31, 2023 (in thousands):

Net sales

$

1,523,975

Gross profit

$

784,446

Earnings before provision for income taxes

$

96,854

Net Earnings

$

72,906

Share Repurchase Programs

Under our current share repurchase program, we may from time-to-time repurchase our common stock on the open market. During the six months ended March 31, 2023, no shares were repurchased in connection with our share repurchase program. During the six months ended March 31, 2022, we repurchased 6.8 million shares of our common stock for $130.3 million under our share repurchase program. See Note 4, Stockholders’ Equity , for more information about our share repurchase program.

Contractual Obligations

Other than the repayment of our TLB 2024 and entering into the TLB 2030 as discussed above, there have been no material changes outside the ordinary course of our business in any of our contractual obligations since September 30, 2022.

Off-Balance Sheet Financing Arrangements

At March 31, 2023 and September 30, 2022, we had no off-balance sheet financing arrangements other than outstanding letters of credit related to inventory purchases and self-insurance programs.

23


Critical Accounting Estimates

There have been no material changes to our critical accounting estimates or assumptions since September 30, 2022.

Recent Accounting Pronouncements

There have been no recent accounting pronouncements issued that will have a material impact to our business.

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

As a multinational corporation, we are subject to certain market risks including foreign currency fluctuations, interest rates and government actions. Since September 30, 2022, the only material change in our market risks relates to interest rate risks resulting from the early settlement of our interest rate caps which previously helped mitigate our exposure to interest rates changes on our prior term loan B. In April 2023, we entered into an interest rate swap. See Note 12, Subsequent Event , for more information. At March 31, 2023, we had $434.0 million in outstanding floating interest rate debt, and a 1.0 percentage point interest rate increase would negatively impact our annual interest expense and cash flows by $4.3 million.

See our disclosures about market risks contained in Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2022.

Item 4.  Controls and Procedures

Controls Evaluation and Related CEO and CFO Certifications. Our management, with the participation of our principal executive officer (“CEO”) and principal financial officer (“CFO”), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2023. The controls evaluation was conducted by our Disclosure Committee, comprised of senior representatives from our finance, accounting, internal audit, and legal departments under the supervision of our CEO and CFO.

Certifications of our CEO and our CFO, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Quarterly Report. This “Controls and Procedures” section includes the information concerning the controls evaluation referred to in the certifications and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Limitations on the Effectiveness of Controls. We do not expect that our disclosure controls and procedures will prevent all errors and all fraud. A system of controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the system are met. Because of the limitations in all such systems, no evaluation can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Furthermore, the design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how unlikely. Because of these inherent limitations in a cost-effective system of controls and procedures, misstatements or omissions due to error or fraud may occur and not be detected.

Scope of the Controls Evaluation. The evaluation of our disclosure controls and procedures included a review of their objectives and design, our implementation of the controls and procedures and the effect of the controls and procedures on the information generated for use in this Quarterly Report. In the course of the evaluation, we sought to identify whether we had any data errors, control problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, was being undertaken if needed. This type of evaluation is performed on a quarterly basis so that conclusions concerning the effectiveness of our disclosure controls and procedures can be reported in our Quarterly Reports on Form 10-Q and our Annual Reports on Form 10-K. Many of the components of our disclosure controls and procedures are also evaluated by our internal audit department, by our legal department and by personnel in our finance organization. The overall goals of these various evaluation activities are to monitor our disclosure controls and procedures on an ongoing basis and to maintain them as dynamic systems that change as conditions warrant.

Conclusions regarding Disclosure Controls. Based on the required evaluation of our disclosure controls and procedures, our CEO and CFO have concluded that, as of March 31, 2023, we maintain disclosure controls and procedures that are effective in providing reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting. During our most recent fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

24


PART II — OTHER INFORMATION

We are involved, from time to time, in various claims and lawsuits incidental to the conduct of our business in the ordinary course. We carry insurance coverage in such amounts in excess of our self-insured retention as we believe to be reasonable under the circumstances and that may or may not cover any or all of our liabilities in respect of these matters. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position, cash flows or results of operations.

We are subject to a number of U.S., federal, state and local laws and regulations, as well as the laws and regulations applicable in each foreign country or jurisdiction in which we do business. These laws and regulations govern, among other things, the composition, packaging, labeling and safety of the products we sell, the methods we use to sell these products and the methods we use to import these products. We believe that we are in material compliance with such laws and regulations, although no assurance can be provided that this will remain true going forward.

Item 1A.  Risk Factors

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors contained in Item 1A. “Risk Factors” in Part I of our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, which could materially affect our business, financial condition or future results. There have been no material changes from the risk factors disclosed in such Annual Report. The risks described in such Annual Report and herein are not the only risks facing our company.

25


Item 6.  Exhibits

Exhibit No.

Description

3.1

Third Restated Certificate of Incorporation of Sally Beauty Holdings, Inc., dated January 30, 2014, which is incorporated herein by reference from Exhibit 3.3 to the Company’s Current Report on Form 8-K filed on January 30, 2014

3.2

Amended and Restated Bylaws of Sally Beauty Holdings, Inc., dated April 26, 2017, which is incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on April 28, 2017

10.1

Credit Agreement, dated as of February 28, 2023, by and among Sally Holdings LLC, Sally Capital, Inc., Bank of America, N.A., as Administrative Agent and Collateral Agent, and the lenders and other parties, which is incorporated herein by reference from Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on March 1, 2023

22

List of Subsidiary Guarantors*

31.1

Rule 13a-14(a)/15d-14(a) Certification of Denise Paulonis*

31.2

Rule 13a-14(a)/15d-14(a) Certification of Marlo M. Cormier*

32.1

Section 1350 Certification of Denise Paulonis*

32.2

Section 1350 Certification of Marlo M. Cormier*

101

The following financial information from our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Earnings; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders’ Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements.

104

The cover page from our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, formatted in Inline XBRL (contained in Exhibit 101).

* Included herewith

26


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SALLY BEAUTY HOLDINGS, INC.

(Registrant)

Date:  May 4, 2023

By:

/s/ Marlo M. Cormier

Marlo M. Cormier

Senior Vice President, Chief Financial Officer

For the Registrant and as its Principal Financial Officer

27

TABLE OF CONTENTS